Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Chimerix Inc (NQ: CMRX )

2.020 +0.210 (+11.60%)
Streaming Delayed Price Updated: 11:29 AM EDT, May 19, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 5,006,292
Open 2.000
Bid (Size) 2.020 (31)
Ask (Size) 2.030 (14)
Prev. Close 1.810
Today's Range 1.870 - 2.080
52wk Range 1.570 - 9.290
Shares Outstanding 86,249,744
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Stocks That Hit 52-Week Lows On Tuesday
On Tuesday, 123 stocks made new 52-week lows. 
Via Benzinga
Recap: Chimerix Q1 Earnings
Chimerix (NASDAQ:CMRX) reported its Q1 earnings results on Monday, May 16, 2022 at 07:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga

Performance

YTD
-70.29%
-70.29%
1 Month
-55.31%
-55.31%
3 Month
-65.94%
-65.94%
6 Month
-68.19%
-68.19%
1 Year
-74.94%
-74.94%

More News

Read More
Earnings Scheduled For May 16, 2022
Via Benzinga
73 Biggest Movers From Yesterday
Via Benzinga
Mid-Afternoon Market Update: Dow Jumps 300 Points; Crude Oil Rises Over 3%
Via Benzinga
Chimerix Confirms Ongoing Negotiations With BARDA On Smallpox Medicine Contract
Via Benzinga
Chimerix: Q4 Earnings Insights
Via Benzinga
Earnings Scheduled For March 1, 2022
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Mid-Day Market Update: Dow Edges Higher; Data Storage Shares Surge
Via Benzinga
41 Stocks Moving In Monday's Mid-Day Session
Via Benzinga
MANT Stock Pops 15% on News That Carlyle Group Will Acquire ManTech
Via InvestorPlace
Chimerix (CMRX) Stock Plummets 60% After Q1 Earnings Disappointment
Via InvestorPlace
Mid-Morning Market Update: Markets Open Lower; Dow Drops 70 Points
Via Benzinga
The Week Ahead In Biotech: Gene & Cell Therapy Conference, Tapering Earnings News, OKYO Pharma IPO And More
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
Via InvestorPlace
Chimerix's Earnings Outlook
Via Benzinga
The Daily Biotech Pulse: Pfizer-BioNTech COVID-19 Booster Data In Kids, Regeneron's COVID-19 Therapy Decision Pushed, Protagonist's Rusfertide Breakthrough Tag Update And More
Via Benzinga
Looking Into Chimerix's Return On Capital Employed
Via Benzinga
Chimerix's CMX521 Antiviral Program Shows Potential Against COVID-19 In Preclinical Studies
Via Benzinga
10 Biggest Price Target Changes For Wednesday
Via Benzinga
35 Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
Exposures Product Safety
52 Biggest Movers From Yesterday
Via Benzinga
Exposures Product Safety
20 Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Exposures Product Safety
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.